Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag has been updated from v3.6.0 to v3.6.2, with the older tag removed. This update seems to reflect a backend or template change rather than a user-facing content modification.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew navigation items and help sections were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision note to v3.6.0. The recruitment status now shows no longer looking for participants.SummaryDifference0.5%

- Check24 days agoChange DetectedPage revision label updated from v3.5.4 to v3.5.5, indicating a minor revision of the document. This change signals a version bump and does not modify the stated study details or eligibility information.SummaryDifference0.0%

- Check38 days agoChange DetectedSponsor for the MOR106 study is updated, switching the listed sponsor from Galapagos NV to Lakefront Biotherapeutics NV.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page shows Revision: v3.5.4 instead of v3.5.3, representing a minor version update. This update does not modify the visible content or functionality of the page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor technical update without changing the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.